Just In
- 21 min ago Kamada Ekadashi 2024 Wishes: Greetings, Messages, Texts, Images, Twitter Status And Instagram Captions
- 54 min ago Deepika Padukone's 6 Refreshing Skincare Tips to Beat the Summer Heat
- 6 hrs ago 7 Questions You Should Ask Your Partner Before Getting Into An Arranged Marriage
- 9 hrs ago Heeramandi: Designers Rimple And Harpreet Craft Inspiring 300 Outfits, Know The Details Here!
Don't Miss
- Sports Who Won Yesterday's IPL Match 33? PBKS vs MI, IPL 2024 on April 17: Mumbai Indians Escape Last-Ditched Fight by Punjab Kings To Win
- Movies Do Aur Do Pyaar OTT Release Date & Platform: When & Where To Watch Vidya Balan’s Film After Theatrical Run?
- Finance Wipro Q4 Results Preview: Weak Demand Likely To Drag Revenue Sequentially, EBIT Margins Seen Stable
- News BRS Chief K Chandrasekhar Rao Slams BJP, Says K Kavitha's Arrest Is Vendetta Politics
- Automobiles Aprilia RS 457 Accessories: A Detailed Look At The Prices
- Education Karnataka SSLC Result 2024 Soon, Know How to Check Through Website, SMS and Digilocker
- Technology Nothing Ear, Ear a With ANC, Up to 42.5 Hours of Battery Launched; Check Price and Availability
- Travel Telangana's Waterfall: A Serene Escape Into Nature's Marvels
gene
Courtesy: Reuters
A US biotechnology firm says it has developed a new technique to produce gene that could be used to produce treatments for human diseases.
The technology, devised by scientists at the privately-owned California company Origen Therapeutics and researchers at the University of California, Davis, may also lead to improved poultry production and chickens resistant to avian flu.
Origen is one of several biotech groups that have been working on new ways to produce human antibodies and proteins in eggs, milk and farm crops.
''We now have a technology to genetically modify chickens in a very precise way,'' Robert Kay, the president of Origen, said in an interview yesterday.
He said the technology would allow scientists to alter the chicken genome in ways that could allow them to produce drugs in very large quantities and develop new therapies.
The technology is based on genetically engineering primordial germ cells, the precursor cells to sperm and eggs, in chickens.
Marie-Cecile van de Lavoir, the senior scientist at Origen, said the cells were the key to introducing genetic elements into chickens and to passing them on to future generations.
The company hopes to use the technology, described in the journal Nature, to produce antibody-based therapies for illnesses and to overcome the problem of drug resistance in certain diseases.
- wellnessFocus On Preventive Steps To Ease Burden Of Genetic Diseases: VP
- wellnessCovid-19 Severity Among Elderly May Be Due To Genetic Reasons, Study Reveals
- wellnessGenetic Link Between Routine Blood Test Results And Mental Health Disorders: Study
- kidsFirst Gene Therapy For Tay-Sachs Disease Successfully Given To Two Children
- healthScientists Develop New AI Model To Discover Genetic Risk Factors For Motor Neurone Disease
- diabetesKnow About Genetics Of Type 1 And Type 2 Diabetes And How To Prevent If It Runs In The Family
- disorders cureAchondroplasia: Causes, Symptoms, Diagnosis And Treatment
- disorders cureHuntington’s Disease: Causes, Symptoms, Diagnosis And Treatment
- disorders cureGene Editing: Everything You Need To Know
- wellnessRare Gene Variant Behind Schizophrenia Identified
- newsScientists Discover Gene That Causes Vision Loss; Foods That Are Good For Your Sight
- wellnessHeart Disease Preventing Gene Identified In Greeks